Beyond Genomix develops a multiplexed platform for ncDNA analysis, focusing on telomere and senescence pathways to identify molecular patterns linked to age-associated diseases. Their technology provides actionable insights for diagnostics and drug discovery by analyzing multi-omics data derived from extensive clinical studies.
Funding
Funding not disclosed
Founders
Product
Problem
Age-associated diseases lack effective diagnostic tools for early detection and personalized treatment strategies. Current methods often fail to integrate the complex interplay of genomic, telomeric, and senescence-related factors that contribute to disease onset and progression. This limitation hinders the development of targeted therapies and preventative measures for age-related conditions.
Solution
Beyond Genomix offers a multi-omics discovery platform that analyzes key hallmarks of aging, including genomics, telomeres, and senescence, to identify molecular patterns associated with age-related diseases. The platform leverages a high-throughput technology for telomere analysis and AI-powered senescence biomarker analysis, providing a comprehensive view of aging pathways. By integrating multi-omics data derived from clinical studies, the platform generates actionable insights for diagnostics and drug discovery. The machine learning platform performs end-to-end analysis of aging hallmarks and key genetic variants, enabling the discovery and characterization of new patterns in age-associated diseases. This integrated approach facilitates the development of therapeutics and diagnostics for healthy longevity and reproductive health.
Target Audience
The primary target audience includes researchers and pharmaceutical companies focused on developing diagnostics and therapeutics for age-related diseases, as well as clinicians specializing in healthy longevity and reproductive health.
Features
- High-throughput telomere analysis technology for identifying novel patterns in age-related diseases
- AI-powered senescence biomarker analysis for unbounded discovery of age-related disease patterns
- Genomics pipeline that delves into molecular patterns altering telomere and senescence pathways
- Proprietary integrated multi-omics analytics to provide actionable insights into age-related diseases
- End-to-end analysis of hallmarks of aging, including telomeres, senescence, and key genetic variants
- Machine learning platform built on clinical studies for therapeutics and diagnostics